HOME >> MEDICINE >> NEWS
Bone Marrow With Heart And Lung Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh

s, acute cellular rejection in the first six months occurred in 38 percent of those who received bone marrow, compared to 82 percent of those who did not. Most of the rejection episodes in the group of bone marrow-augmented patients were mild as compared to moderate to severe in the recipients who did not receive bone marrow. There were no differences in the incidence of chronic rejection for the two groups of heart recipients.

In lung transplant patients, the most significant result was a reduced incidence of chronic rejection, a process that prevents air to pass through the lung's bronchioles. Chronic rejection occurred in 9 percent of the bone marrow patients and in 42 percent of those who did not receive bone marrow. In addition, those lung patients receiving bone marrow had higher measures of donor-specific hyporeactivity. This indicates that the recipient's immune defense is capable of fighting unwanted infections but is less likely to initiate an attack against the donor organ.

In studies to detect chimerism in a small subset of patients a year after transplantation, levels appeared to be higher in those who received bone marrow. The safety of the bone marrow procedure was also a parameter studied. Patients were not pre-treated with irradiation to "make space" for the bone marrow, nor was the bone marrow modified in any way. As a result, the researchers believe the risk of graft vs. host disease (GVHD) was minimized. GVHD, a common complication of bone marrow transplantation, occurs when donor immune cells attack recipient tissues.

"The results in these patients who received the extra boost of donor immune system cells indicate the procedure is safe and augments the cellular environment we believe is necessary for long-term acceptance of a transplanted organ. Chimerism is a prerequisite for but not synonymous with tolerance," Dr. McCurry reported.

The study of combined solid organ and bone marrow transplants is the clinical centerpi
'"/>

Contact: Lisa Rossi
rossiL@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
24-Apr-1999


Page: 1 2 3

Related medicine news :

1. Marrow injection gets damaged hearts moving
2. Less Toxic Bone Marrow Transplant Technique May Have More Powerful Anti-Cancer Effect
3. Organ Transplants Helped By Donor Bone Marrow, University Of Pittsburgh Researchers Report At National Transplant Meetings
4. Bone Marrow With Organ Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
5. Duke Researchers Identify New Pulmonary Syndrome Associated With Bone Marrow Transplantation For Breast Cancer
6. The European Society of Cardiology launches Women at Heart
7. Heart surgeons publish death rates
8. Heart attack treatment gap may be closing for women
9. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
10. Brenner Childrens Hospital named to NIH Pediatric Heart Network
11. Heart patients treated by non-cardiologists less likely to receive medications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology:
Cached News: